# Low-field MRI for Breast Cancer Screening

> **NCT05486520** · NA · ENROLLING_BY_INVITATION · sponsor: **Massachusetts General Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Breast Benign
- Malignant Neoplasm of Breast
- Breast Malignant Tumor

## Interventions

- **DEVICE:** Magnetic Resonance Imaging (MRI)

## Key facts

- **NCT ID:** NCT05486520
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2022-09-01
- **Primary completion:** 2026-09-15
- **Final completion:** 2026-10-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-05-12

## Collaborators

- National Institutes of Health (NIH)

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05486520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05486520, "Low-field MRI for Breast Cancer Screening". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05486520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*